
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum is a global healthcare company with a broad portfolio of advanced wound care, surgical, dental, and healthcare software products. Management has taken decisive steps to unlock value for shareholders, including divesting non-core businesses and initiating a shareholder-friendly capital return program. Further, the announced intent to separate the HIS segment highlights management's commitment to shareholder value creation and offers a potential catalyst for the stock. While there are some risks to consider, such as competition and potential dilution from the separation, the fundamental factors and strategic initiatives support a positive outlook on Solventum's stock.
Bears say
Solventum is facing challenges with the separation of their HIS segment and negative organic growth, with a decrease in Q3 organic growth by 3-4% and a flat organic growth for H2 2026. The company has made minor adjustments to their financials, with an increase in FY26 guidance for organic growth to 2.5%-3.0%. However, there has been a decrease in MedSurg OMs despite growth driven by differentiated and higher-value products.
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares